form 8-k





                                       SECURITIES AND EXCHANGE COMMISSION

                                             WASHINGTON, D.C. 20549
                                     ---------------------------------------

                                                    FORM 8-K



                                                 CURRENT REPORT

                                     Pursuant to Section 13 or 15(d) of the
                                         Securities Exchange Act of 1934



             Date of Report (Date of earliest event reported): September 11, 2001 (August 31, 2001)
------------------------------------------------------------------------------------------------------------------------------------------------

                                       INNOVATIVE CLINICAL SOLUTIONS, LTD.
------------------------------------------------------------------------------------------------------------------------------------------------
                             (Exact name of registrant as specified in its charter)

                                                    Delaware

-----------------------------------------------------------------------------------------------------------------------------------------------
                                 (State or other jurisdiction of incorporation)

                          0-27568                                                               65-0617076
------------------------------------------------------------------------------------------------------------------------------------------------
                          (Commission File Number) (IRS Employer Identification Number)

                               10 Dorrance Street, Suite 400, Providence, RI 02903
------------------------------------------------------------------------------------------------------------------------------------------------
                                    (Address of principal executive offices)

                                                 (401) 831-6755
------------------------------------------------------------------------------------------------------------------------------------------------
                              (Registrant's telephone number, including area code)

                                                       N/A
------------------------------------------------------------------------------------------------------------------------------------------------
                          (Former name or former address, if changed since last report)







Item 5:           Other Events.
------            ------------

Resignation of Adrian Otte
--------------------------

         The Registrant  announced that its Chief Operating Officer - Clinical Studies, Dr. Adrian Otte, has tendered
his  resignation  and the  Registrant has accepted his  resignation.  Dr. Otte resigned to pursue an opportunity as a
senior  manager for major  pharmaceutical  company.  Dr.  Otte's  resignation  will be effective  September 14, 2001.
Gary S.  Gillheeney,  the  Registrant's  Chief  Financial  Officer will serve as interim  Chief  Operating  Officer -
Clinical Studies until a suitable replacement for Dr. Otte can be retained.

Sale of Oncology
----------------

         On August 31, 2001,  the  Registrant  sold  certain of its assets,  specifically  its oncology  clinical
studies (OCS) network of 23 sites across the country.  The  Registrant  received $2.5 million in cash for the OCS
network and plans to use that cash to focus on its core competencies.

Item 7.  Financial Statements and Exhibits.

(a)      Financial statements of business acquired.

         Not Applicable

(b)      Pro forma financial information

         Not Applicable

(c)      Exhibits

         None.







                                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                                              INNOVATIVE CLINICAL SOLUTIONS, LTD



                                                              By:      /s/ Michael T. Heffernan
                                                                       -----------------------------------
                                                                       Michael T. Heffernan
                                                                       Chief Executive Officer


Date:  August 11, 2001